Calithera Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Calithera Biosciences's estimated annual revenue is currently $9.8M per year.
- Calithera Biosciences's estimated revenue per employee is $270,833
- Calithera Biosciences's total funding is $200.9M.
- Calithera Biosciences's current valuation is $39.3M. (January 2022)
Employee Data
- Calithera Biosciences has 36 Employees.
- Calithera Biosciences grew their employee count by -37% last year.
Calithera Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Sr. VP Development | Reveal Email/Phone |
3 | VP Medical Affairs | Reveal Email/Phone |
4 | SVP, Drug Discovery | Reveal Email/Phone |
5 | VP, Clinical Development | Reveal Email/Phone |
6 | Executive Director, Finance | Reveal Email/Phone |
7 | Senior Director IT | Reveal Email/Phone |
8 | Director, Translational Science | Reveal Email/Phone |
9 | DMPK Senior Research Associate | Reveal Email/Phone |
10 | Investor Relations Associate | Reveal Email/Phone |
Calithera Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $102.7M | 511 | 25% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $38.6M | 192 | 3% | N/A | N/A |
#4 | $35M | 127 | 2% | $62.5M | N/A |
#5 | $36.6M | 182 | 18% | N/A | N/A |
#6 | $131.9M | 656 | -3% | N/A | N/A |
#7 | $133.5M | 664 | N/A | N/A | N/A |
#8 | $72.8M | 362 | -4% | N/A | N/A |
#9 | $551.9M | 1716 | -2% | N/A | N/A |
#10 | $11.7M | 58 | 12% | N/A | N/A |
What Is Calithera Biosciences?
Calithera is a development stage pharmaceutical company committed to discovering and developing novel small molecule therapeutics for the treatment of cancer. We are applying our scientific expertise to build a pipeline of unique anti- cancer drugs that selectively target metabolic and apoptotic pathways critical to tumor growth and survival.
keywords:N/A
$200.9M
Total Funding
36
Number of Employees
$9.8M
Revenue (est)
-37%
Employee Growth %
$39.3M
Valuation
N/A
Accelerator
Calithera Biosciences News
Calithera Biosciences Inc (CALA) stock is down -82.08% over the last 12 months, and the average rating from Wall Street analysts is a Strong...
Thinking about buying stock in AT&T, Calithera Biosciences, Aterian, Mandiant, or Xerox? InvestorsObserver (PRNewsfoto/InvestorsObserver)...
Calithera Biosciences is a clinical-stage, precision oncology biopharmaceutical company developing targeted therapies to redefine treatment for...
Targeting cancer, differently. Susan M. Molineaux, Ph.D. | Founder, President & Chief Executive Officer NASDAQ: CALA CALITHERA® and the Calithera Logos are trademarks or registered trademarks of Calithera Biosciences, Inc. All rights reserved. Forward-Looking Statements This presentation an ...
Calithera Biosciences, a South San Francisco, CA-based biotechnology company focused on the development of novel cancer therapeutics, completed a $35m Series D financing. The round was led by Adage Capital Partners, LP., with participation from new investors Longwood Fund and two other institut ...
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.2M | 36 | -5% | N/A |
#2 | $7.8M | 36 | 6% | N/A |
#3 | $3.5M | 37 | -5% | N/A |
#4 | $3M | 38 | -12% | N/A |
#5 | $10.7M | 38 | 3% | N/A |